MedPath

Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?

Not Applicable
Completed
Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
Procedure: Pancreaticoduodenectomy with Extended lymphadenectomy
Procedure: Pancreaticoduodenectomy with Standard lymphadenectomy
Registration Number
NCT02787187
Lead Sponsor
Ruijin Hospital
Brief Summary

The purpose of this study is to compare outcomes of patients undergoing standard or extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
230
Inclusion Criteria
  • Pathologic diagnosis of pancreatic ductal adenocarcinoma
  • Signed the informed consents
Exclusion Criteria
  • Pathologic diagnosis of other pancreatic cancers
  • Pre-operative anti-cancer treatment
  • Recurrence patients
  • Patients with contraindication(hepatic/ respiratory/ renal dysfunction, etc )
  • Pre operative exam: Total bilirubin more than 250µmol/L
  • AJCC stage IV
  • Operation non radical

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Extended resectionPancreaticoduodenectomy with Extended lymphadenectomyPancreaticoduodenectomy (child's digestive reconstruction)extended lymphadenectomy No8p 12a 12p 14c 14d 16
Standard resectionPancreaticoduodenectomy with Standard lymphadenectomyPancreaticoduodenectomy (child's digestive reconstruction); Standard lymphadenectomy: No 5 6 8a 12b1 12b2 12c 13a 13b 14a 14b 17a 17b
Primary Outcome Measures
NameTimeMethod
All-cause mortality3yrs post-operation
Secondary Outcome Measures
NameTimeMethod
all-cause mortality1yr post-operation

Trial Locations

Locations (1)

Shanghai Ruijin Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath